Ellevest, Inc. Incyte Corp Transaction History

Ellevest, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$70.23 - $86.01 $13,273 - $16,255	189 Added 52.65%	548 $39,000
Q4 2022 Feb 03, 2023	SELL	$67.18 - $84.11 $3,829 - $4,794	-57 Reduced 13.7%	359 $28,000
Q3 2022 Nov 02, 2022	BUY	$66.18 - $82.86 $4,831 - $6,048	73 Added 21.28%	416 $28,000
Q2 2022 Jul 18, 2022	SELL	$66.18 - $83.18 $21,839 - $27,449	-330 Reduced 49.03%	343 $26,000
Q1 2022 Apr 19, 2022	BUY	$66.02 - $79.71 $30,105 - $36,347	456 Added 210.14%	673 $53,000
Q4 2021 Jan 24, 2022	BUY	$63.34 - $74.11 $13,744 - $16,081	217 New	217 $16,000
Q3 2021 Oct 19, 2021	SELL	$68.67 - $84.02 $26,918 - $32,935	-392 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$79.87 - $87.53 $1,437 - $1,575	18 Added 4.81%	392 $33,000
Q1 2021 May 03, 2021	SELL	$76.02 - $100.5 $88,335 - $116,781	-1,162 Reduced 75.65%	374 $30,000
Q4 2020 Feb 04, 2021	BUY	$80.74 - $97.7 $62,573 - $75,717	775 Added 101.84%	1,536 $134,000
Q3 2020 Oct 26, 2020	BUY	$85.07 - $109.69 $18,204 - $23,473	214 Added 39.12%	761 $68,000
Q2 2020 Jul 06, 2020	BUY	$74.18 - $108.93 $20,028 - $29,411	270 Added 97.47%	547 $57,000
Q1 2020 Apr 13, 2020	BUY	$63.18 - $85.97 $12,320 - $16,764	195 Added 237.8%	277 $20,000
Q4 2019 Feb 05, 2020	BUY	$73.04 - $95.72 $5,989 - $7,849	82 New	82 $7,000
Q3 2019 Oct 08, 2019	SELL	$72.82 - $86.52 $2,403 - $2,855	-33 Closed	0 $0
Q2 2019 Aug 20, 2019	BUY	$73.52 - $88.7 $2,426 - $2,927	33 New	33 $3,000

642

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.